Mixed treatment comparison of infliximab with ustekinumab in patients with moderate to severe psoriasis

被引：0
|
作者：
Fan, T. [1 ]
Bennett, H. [2 ]
Smith, N. [2 ]
Marin, M. [2 ]
Shuvayu, S. [1 ]
机构：
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] OptumInsight, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 165卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E38 / E39
页数：2
相关论文
共 50 条
  • [1] Ustekinumab for the treatment of moderate to severe psoriasis
    Gospodarevskaya, E.
    Picot, J.
    Cooper, K.
    Loveman, E.
    Takeda, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 61 - 66
  • [2] COMPARISON OF INFLIXIMAB AND USTEKIMUMAB FOR TREATMENT OF MODERATE TO SEVERE PSORIASIS: A MIXED TREATMENT META-ANALYSIS
    Fan, T.
    Bennett, H.
    Smith, N.
    Marin, M.
    Sen, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A410 - A411
  • [3] COMPARISON OF USTEKINUMAB WITH OTHER BIOLOGIC AGENTS FOR TREATMENT OF MODERATE-TO-SEVERE PSORIASIS: A BAYESIAN MIXED TREATMENT COMPARISON APPROACH
    Lin, V
    Ringold, S.
    Devine, B.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A99 - A99
  • [4] Pooled efficacy of infliximab for the treatment of patients with moderate to severe psoriasis
    Menter, A
    Papp, K
    Guzzo, C
    Li, S
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB222 - AB222
  • [5] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
    Griffiths, Christopher E. M.
    Strober, Bruce E.
    van de Kerkhof, Peter
    Ho, Vincent
    Fidelus-Gort, Roseanne
    Yeilding, Newman
    Guzzo, Cynthia
    Xia, Yichuan
    Zhou, Bei
    Li, Shu
    Dooley, Lisa T.
    Goldstein, Neil H.
    Menter, Alan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02): : 118 - 128
  • [6] Efficacy of Ustekinumab in the Treatment of Moderate-Severe Psoriasis
    Jimenez-Puya, R.
    Moreno, J. C.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 : 16 - 24
  • [7] Pooled efficacy of infliximab for the treatment of patients with moderate-to-severe psoriasis
    Menter, A.
    Papp, K.
    Guzzo, C.
    Li, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 249 - 249
  • [8] Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis
    Talamonti, M.
    Galluzzo, M.
    Teoli, M.
    Bavetta, M.
    Chimenti, S.
    Costanzo, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E34 - E34
  • [9] The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
    Dapavo, Paolo
    Vujic, Igor
    Fierro, Maria Teresa
    Quaglino, Pietro
    Sanlorenzo, Martina
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (04) : 736 - 739
  • [10] Ustekinumab and TNF-inhibitors in the treatment of moderate to severe psoriasis
    Garcia Lopez, Isabel
    Herranz Alonso, Ana
    Rodriguez Gonzalez, Carmen Guadelupe
    Castillo Romera, Isabel
    Pernia Lopez, Sagrario
    Sanjurjo Saez, M.
    [J]. EJHP PRACTICE, 2011, 17 (01): : 46 - 50
12345